Search

Your search keyword '"Li, Si-Ming"' showing total 123 results

Search Constraints

Start Over You searched for: Author "Li, Si-Ming" Remove constraint Author: "Li, Si-Ming" Database Unpaywall Remove constraint Database: Unpaywall
123 results on '"Li, Si-Ming"'

Search Results

3. Integration of MRI-Based Radiomics Features, Clinicopathological Characteristics, and Blood Parameters: A Nomogram Model for Predicting Clinical Outcome in Nasopharyngeal Carcinoma

16. Mucosal melanoma staging and classification: Firstly established.

28. A phase I clinical trial of CM082 (X-82) in combination with everolimus for treatment of metastatic renal cell carcinoma.

30. OrienX010 oncolytic viral therapy in phase Ic trial of intralesional injection in liver metastases among patients with stage IV melanoma after standard treatment.

31. Natural killer cells as a predictive biomarker for response to anti-PD-1 therapy in patients with advanced solid tumors.

32. Multivariate analysis of prognostic factors among 706 mucosal melanoma patients.

38. A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma (NCT02023710).

39. A prospective multicenter phase II study of sorafenib combined with cisplatin plus gemcitabine for the treatment of patients with advanced renal collecting duct carcinoma (NCT01762150).

45. A randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced mucosal melanoma.

47. A randomized, open-label, multi-center phase II study to compare bevacizumab plus sorafenib versus sorafenib for the third-line treatment of patients with metastatic renal cell carcinoma (NCT02330783).

Catalog

Books, media, physical & digital resources